Search research articles
Contact Us
Filters
Showing results (21-30 of 78) with videos related to
Page
of 8
Sort By:
International Journal of Molecular Sciences
|
September 9, 2022
<sup>11</sup>C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to <sup>18</sup>F-FDG PET/CT and Prognostic Value
Maria I Morales-Lozano, Paula Rodriguez-Otero, Lidia Sancho, et al.
Transplantation
|
September 25, 2012
Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation
Anna D Petropoulou, Raphael Porcher, Regis Peffault de Latour, et al.
Blood
|
December 6, 2014
Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
Régis Peffault de Latour, Véronique Fremeaux-Bacchi, Raphaël Porcher, et al.
Blood Cancer Journal
|
February 2, 2024
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
Paula Rodriguez-Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, et al.
Blood Cancer Journal
|
June 19, 2021
KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma
Sundar Jagannath, Yi Lin, Hartmut Goldschmidt, et al.
Blood
|
May 23, 2019
Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma
Ajai Chari, Joaquín Martinez-Lopez, María-Victoria Mateos, et al.
Cancer Medicine
|
July 28, 2025
Real-World Treatment Patterns and Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and 1-3 Prior Lines of Therapy: Optum Database
Binod Dhakal, Hermann Einsele, Jordan M Schecter, et al.
Hematological Oncology
|
July 6, 2022
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant
Cirino Botta, Emilia Gigliotta, Bruno Paiva, et al.
Haematologica
|
December 20, 2011
Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning
Johanna Konopacki, Raphaël Porcher, Marie Robin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2019
The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma
Laura Moreno, Cristina Perez, Aintzane Zabaleta, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 78) with videos related to
Sort By:
Page
of 8
International Journal of Molecular Sciences
|
September 9, 2022
<sup>11</sup>C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to <sup>18</sup>F-FDG PET/CT and Prognostic Value
Maria I Morales-Lozano, Paula Rodriguez-Otero, Lidia Sancho, et al.
Transplantation
|
September 25, 2012
Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation
Anna D Petropoulou, Raphael Porcher, Regis Peffault de Latour, et al.
Blood
|
December 6, 2014
Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
Régis Peffault de Latour, Véronique Fremeaux-Bacchi, Raphaël Porcher, et al.
Blood Cancer Journal
|
February 2, 2024
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
Paula Rodriguez-Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, et al.
Blood Cancer Journal
|
June 19, 2021
KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma
Sundar Jagannath, Yi Lin, Hartmut Goldschmidt, et al.
Blood
|
May 23, 2019
Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma
Ajai Chari, Joaquín Martinez-Lopez, María-Victoria Mateos, et al.
Cancer Medicine
|
July 28, 2025
Real-World Treatment Patterns and Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and 1-3 Prior Lines of Therapy: Optum Database
Binod Dhakal, Hermann Einsele, Jordan M Schecter, et al.
Hematological Oncology
|
July 6, 2022
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant
Cirino Botta, Emilia Gigliotta, Bruno Paiva, et al.
Haematologica
|
December 20, 2011
Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning
Johanna Konopacki, Raphaël Porcher, Marie Robin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2019
The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma
Laura Moreno, Cristina Perez, Aintzane Zabaleta, et al.
Page
of 8